Events CRT 2015 (Cardiovascular Research Technologies) Feb. 21-24, 2015MedStar Heart InstituteWashington, D.C.
Read MoreUniversity of Pennsylvania Doses First Patient In Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy To Treat Chronic Heart Failure (HF) Due To Non-Ischemic Cardiomyopathy
News Nov 21, 2014 University of Pennsylvania Doses First Patient In Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy To Treat Chronic Heart Failure (HF) Due To Non-Ischemic Cardiomyopathy CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that creates
Read MoreUniversity of Pennsylvania Doses First Patient in Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy to Treat Chronic Heart Failure (HF) Due to Non-Ischemic Cardiomyopathy
News Nov 20, 2014 University of Pennsylvania Doses First Patient in Phase IIa Clinical Trial Using CardioCell’s Stem Cell Therapy to Treat Chronic Heart Failure (HF) Due to Non-Ischemic Cardiomyopathy PHILADELPHIA — Nov. 20, 2014 — CardioCell LLC, a Stemedica Cell Technologies Inc.
Read MoreCardioCell Scientific Advisory Board Chair Debates in “Strategies for Cardiovascular Repair” Didactic Science Symposium at TCT2014
News Sep 8, 2014 CardioCell Scientific Advisory Board Chair Debates in “Strategies for Cardiovascular Repair” Didactic Science Symposium at TCT2014 WASHINGTON, D.C. – TCT2014 – Sept. 8, 2014 – CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that creates allogeneic
Read MoreCardioCell launches trial to assess stem cell therapy for chronic HF
News Sep 1, 2014 CardioCell launches trial to assess stem cell therapy for chronic HF CardioCell announced the initiation of a phase 2a trial of ischemia-tolerant mesenchymal stem cell therapy for patients with chronic HF due to nonischemic cardiomyopathy. READ FULL ARTICLE
Read MoreClinical Trials – Chronic Heart Failure – CardioCell
News Aug 4, 2014 Clinical Trials - Chronic Heart Failure - CardioCell CardioCell began its Phase IIa trial for chronic heart failure patients with non-ischemic cardiomyopathy. FULL ARTICLE APPEARED IN THE AUGUST 2014 PRINT EDITION
Read MoreCardioCell Begins Phase IIa Clinical Trial Using itMSC Therapy to Treat Chronic Heart Failure HF Due to Non-Ischemic Cardiomyopathy
News Jul 23, 2014 CardioCell Begins Phase IIa Clinical Trial Using itMSC Therapy to Treat Chronic Heart Failure HF Due to Non-Ischemic Cardiomyopathy CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that creates allogeneic stem-cell therapies for cardiovascular
Read MoreFirm begins stem cell therapy trial for treatment of chronic heart failure
News Jul 19, 2014 Firm begins stem cell therapy trial for treatment of chronic heart failure CardioCell has started the Phase IIa trial of its ischemia-tolerant mesenchymal stem cell therapy for patients with chronic heart failure tied to nonischemic cardiomyopathy. READ FULL ARTICLE
Read More